Chen et al. further demonstrated that the synergistic effect of VPA and TMZ for the induction of apoptosis is independent of an intact p53 and suggest a clinical potential for a combined therapy in p53 mutated gliomas. The gene discussed is TP53; the disease is central nervous system cancer.